Michael Panzara
2019
In 2019, Michael Panzara earned a total compensation of $1.3M as Chief Medical Officer at Wave Life Sciences Ltd., a 43% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $135,545 |
|---|---|
| Salary | $451,815 |
| Stock Awards | $675,000 |
| Other | $9,642 |
| Total | $1,272,002 |
Panzara received $675K in stock awards, accounting for 53% of the total pay in 2019.
Panzara also received $135.5K in non-equity incentive plan, $451.8K in salary and $9.6K in other compensation.
Rankings
In 2019, Michael Panzara's compensation ranked 8,129th out of 13,971 executives tracked by ExecPay. In other words, Panzara earned more than 41.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,129 out of 13,971 | 42nd |
Division Manufacturing | 3,206 out of 5,692 | 44th |
Major group Chemicals And Allied Products | 1,214 out of 2,189 | 45th |
Industry group Drugs | 1,033 out of 1,875 | 45th |
Industry Pharmaceutical Preparations | 767 out of 1,387 | 45th |
Source: SEC filing on June 26, 2020.
Panzara's colleagues
We found four more compensation records of executives who worked with Michael Panzara at Wave Life Sciences Ltd. in 2019.